
Table of Contents
ToggleToday, March 30, 2026, the Sensex closed at 71,947 — down a staggering 1,635 points (−2.22%). The Nifty 50 fell to 22,331, shedding 488 points (−2.14%). The culprit? The escalating US-Iran war that has sent global markets into panic mode.
While millions of Indian investors are staring at their screens in fear, there is one legendary investor whose entire philosophy was built for moments exactly like this: Howard Marks, the co-founder of Oaktree Capital Management, who has generated extraordinary returns over four decades by mastering one simple concept — market cycles.
His book “Mastering the Market Cycle” is arguably the most important book ever written about understanding where we are in the cycle. Today, with the Indian market in turmoil, there has never been a better time to understand his framework.
Howard Marks co-founded Oaktree Capital Management in 1995. Today, Oaktree manages over $190 billion in assets. Warren Buffett himself has said: “When I see memos from Howard Marks in my mail, they’re the first thing I open and read.”
Markets always move in cycles. They swing from euphoria to despair, from greed to fear — and back again. These cycles are driven by human psychology. The pendulum never stops at the midpoint — it always swings too far in both directions.
The Sensex has fallen from approximately 82,000 in September 2024 to 71,947 today. Is this because Indian companies suddenly became less valuable? No. The psychological pendulum has swung from greed to fear.
GDP growth is strong, IPOs oversubscribed 100x, everyone thinks they are a genius. This was the Indian market in late 2024 — when the Sensex was at 82,000 and SEBI warned that 90% of F&O traders lose money.
Bad news dominates, investors are fearful, stocks trade below book value. With the Iran war escalation and the 1,635-point crash — the odds are shifting in the aggressive investor’s favour.
India imports 85% of its oil, making the Iran conflict a genuine risk factor. But economic slowdowns create conditions for the next boom.
The RBI tightened limits on banks’ dollar positions. Overleveraged companies will suffer, but debt-free companies like Titan Biotech (BSE: 524717) — trading at ₹458 with zero debt and ₹1,891 crore market cap — will emerge stronger.
Titan Biotech’s profit of ₹27.2 crore on revenue of ₹193 crore demonstrates a business in a niche where competition is limited.
Howard Marks teaches: “The best opportunities are found when people are most fearful.”
Risk is actually lowest when people perceive it as highest, and highest when people perceive it as lowest.
Think of it like a dial from “fully defensive” to “fully aggressive.” Today, with the Sensex at 71,947, Marks would say move the dial toward aggressive — deliberately, buying quality businesses at reasonable prices.
Step 1: Take the market’s temperature. Fear is high, valuations corrected. The market is running “cold.”
Step 2: Assess your psychology. Howard Marks: “Act contrary to prevailing psychology.”
Step 3: Review your portfolio for quality. Titan Biotech: 55.8% promoter holding, debt-free, consistent revenue growth, ₹1,891 crore market cap.
Step 4: Deploy capital gradually. Be “approximately right rather than precisely wrong.”
Step 5: Avoid the F&O trap. SEBI confirms 90% of F&O traders lose money. Invest in quality businesses, not F&O gambling.
With fear high and quality stocks at discounts — the cycle tells us the next few years could offer extraordinary returns for patient investors. This is the philosophy at Multibagger Shares: buy quality, hold through cycles. Quality always wins.
Learn the complete framework: Complete Value Investing Course — Free on YouTube
1. Howard Marks’ philosophy is built on market cycles — we are in the fearful phase now. 2. Markets swing between greed and fear. 3. “Taking the temperature” tells you when to be aggressive or defensive. 4. Sensex at 71,947 after 1,635-point crash = running cold = high future returns. 5. Buy quality gradually, avoid F&O. 6. You cannot predict, but you can prepare.
Disclaimer: This article is for educational purposes only. Manish Goel is a SEBI-registered investment advisor. Consult your financial advisor before making investment decisions. SEBI data confirms over 90% of F&O traders incur net losses.
📢 Join Our Telegram Channel
Get daily value investing lessons, stock analysis & Titan Biotech updates!
✈️ Join @longtermequityy on Telegram
🔔 Free • No spam • Value investing insights daily
Chat with us on WhatsApp